Company Profile
GC Biopharma Corp., a biopharmaceutical company develops and sells pharmaceutical drugs in South Korea and globally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect.
Its portfolio also includes Kenhancer plaster for anti-inflammatory, and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief Albumin-GCC injection (inj.) for hypoalbuminemia and shock in acute hemorrhage, as well as low synthesis of albumin; Antithrombin-III (AT-III) inj. for hereditary antithrombin-III deficiency
Facnyne inj. for hemophilia B. Its portfolio also includes Fibrinogen to treat hypofibrinogenemia and afibrinogenemia, Gamma Globulin for hypogammaglobulinemia and agammaglobulinemia, and GCFLU Quadrivalent and GC FLU pre-filled syringe inj. for prevention of influenza
GreenGene F inj. for bleeding symptom control and hemostasis for persons with hemophilia A GreenGene inj. for bleeding episodes induced by hemophilia A. Its portfolio also includes Greenplast Q for sealing tissues and closing open wounds, and Green-VIII inj. for Hemophilia A with supplies of blood coagulation factor VIII
Hepabig inj. for hepatitis B. Its portfolio also includes Histobulin to treat bronchial asthma, Hunterase for hunter syndrome, and I.V. Hepabig inj. for prevention of hepatitis B recurrence in patients following liver transplantation